University of Rochester Medical Center (URMC) and the NCI Designated Wilmot Cancer Institute (Wilmot) seeks a visionary, inspirational leader with significant experience advancing early phase clinical trials to serve in the inaugural role of Director, Developmental Therapeutics (Director). This position offers the unique opportunity to expand a critical component of Wilmot – the program to support developmental therapeutics and early phase clinical trials – during a significant phase of its growth at one of the foremost academic institutions and the nation's newest NCI Designated Cancer Centers.
Wilmot serves approximately three million people in New York State and conducts pivotal research with the goal of preventing and conquering cancer. Wilmot features an 87-bed flagship cancer center, 13 outpatient locations, and sees more than 7,000 new cancer patients each year. In 2024, Wilmot researchers had $30.9 million in cancer funding, $25.8 million in peer reviewed funding and over $14 million in NCI funding. Wilmot is part of URMC, one of the nation’s leading academic medical centers which ranks among the top quarter of U.S. medical centers in federal research funding and has an overall budget of approximately $6 billion.
The successful Director will bring expertise in early phase oncology clinical trials and will be a collaborative, transparent, visionary leader of teams as well as a strong clinician and investigator. Candidates must possess an MD, MD/PhD, or equivalent, be board certified in an oncology specialty, and possess academic accomplishments to merit appointment at the rank of Associate Professor or higher at University of Rochester and be eligible for licensure in the State of New York.
For more information, email
[email protected].
The pay range for this position is $400,000 – $525,000. The referenced pay range represents the University’s good faith and reasonable estimate of the base range of compensation for this position. Individual salaries will be determined within the job’s salary range and established based on (but not limited to) market data, experience, and expertise of the individual, and with consideration to related position salaries. Alignment of clinical incentive-based compensation also may be applicable and will be discussed during the hiring process.
EOE, including disability/protected veterans
The University of Rochester is committed to fostering, cultivating, and preserving an inclusive and welcoming culture to advance the University’s Mission to Learn, Discover, Heal, Create – and Make the World Ever Better. In support of our values and those of our society, the University is committed to not discriminating on the basis of age, color, disability, ethnicity, gender identity or expression, genetic information, marital status, military/veteran status, national origin, race, religion/creed, sex, sexual orientation, citizenship status, or any other characteristic protected by federal, state, or local law (Protected Classes). This commitment extends to non-discrimination in the administration of our policies, admissions, employment, access, and recruitment of candidates for all persons consistent with our values and based on applicable law.